Family Firm, Inc. Abb Vie Inc. Transaction History

Family Firm, Inc.

$897 Million
Q2 2024

A detailed history of Family Firm, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Family Firm, Inc. holds 4,813 shares of ABBV stock, worth $950,471. This represents 0.09% of its overall portfolio holdings.

Number of Shares

4,813

Previous 4,787 0.54%

Holding current value

$950,471

Previous $871,000 5.28%

% of portfolio

0.09%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$154.79 - $180.76 $4,024 - $4,699	26 Added 0.54%	4,813 $825,000
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $4,954 - $5,645	31 Added 0.65%	4,787 $871,000
Q4 2023 Feb 05, 2024	BUY	$137.6 - $154.97 $5,228 - $5,888	38 Added 0.81%	4,756 $737,000
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $4,408 - $5,103	33 Added 0.7%	4,718 $703,000
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $4,637 - $5,771	35 Added 0.75%	4,685 $631,000
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $4,916 - $5,662	34 Added 0.74%	4,650 $741,000
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $4,287 - $5,141	31 Added 0.68%	4,616 $746,000
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $11,273 - $12,930	84 Added 1.87%	4,585 $615,000
Q2 2022 Dec 01, 2022	BUY	$137.62 - $174.96 $3,990 - $5,073	29 Added 0.63%	4,614 $707,000
Q1 2022 Nov 30, 2022	SELL	$131.98 - $163.75 $6,730 - $8,351	-51 Reduced 1.11%	4,534 $735,000
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $3,330 - $4,213	31 Added 0.69%	4,501 $609,000
Q3 2021 Oct 22, 2021	BUY	$106.4 - $120.78 $3,192 - $3,623	30 Added 0.68%	4,470 $485,000
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $3,051 - $3,399	29 Added 0.66%	4,440 $500,000
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $3,375 - $3,716	33 Added 0.75%	4,411 $477,000
Q4 2020 Jan 20, 2021	BUY	$80.49 - $108.67 $16,741 - $22,603	208 Added 4.99%	4,378 $484,000
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $12,886 - $15,124	-150 Reduced 3.47%	4,170 $365,000
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $19,076 - $25,526	260 Added 6.4%	4,320 $424,000
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $258 - $391	4 Added 0.1%	4,060 $309,000
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $8,367 - $10,469	-116 Reduced 2.78%	4,056 $359,000
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $314 - $378	5 Added 0.12%	4,172 $316,000
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $197 - $251	3 Added 0.07%	4,167 $303,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $308 - $363	4 Added 0.1%	4,164 $336,000
Q4 2018 Feb 05, 2019	BUY	$77.85 - $96.01 $6,850 - $8,448	88 Added 2.16%	4,160 $383,000
Q3 2018 Oct 31, 2018	SELL	$88.91 - $98.84 $37,253 - $41,413	-419 Reduced 9.33%	4,072 $385,000
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $7,990 - $9,454	-89 Reduced 1.94%	4,491 $416,000
Q1 2018 Apr 26, 2018	SELL	$92.01 - $123.21 $7,820 - $10,472	-85 Reduced 1.82%	4,580 $433,000
Q4 2017 Feb 07, 2018	BUY	$89.56 - $98.21 $268 - $294	3 Added 0.06%	4,665 $451,000
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $558 - $713	8 Added 0.17%	4,662 $414,000
Q2 2017 Aug 08, 2017	BUY	N/A	4,654	4,654 $337,000

Others Institutions Holding ABBV

# of Institutions

3,695

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Firm, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Firm, Inc. with notifications on news.

Account